SciELO - Scientific Electronic Library Online

 
vol.65 issue2Pilot study to identify anthropometric indices associated with metabolic syndrome risk markers in school-aged Mexican childrenEvaluation of anti-arrhythmic effect of propafenone in children with supraventricular paroxistic tachycardia author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Boletín médico del Hospital Infantil de México

Print version ISSN 1665-1146

Abstract

HERRERA-SILVA, Jorge Carlos; TREVINO-MOORE, Aída  and  LOPEZ-BELTRAN, Ana Laura. Metabolic syndrome in cancer patients under chemotherapy treatment. Bol. Med. Hosp. Infant. Mex. [online]. 2008, vol.65, n.2, pp.110-120. ISSN 1665-1146.

Introduction. Metabolic syndrome is one of the main health problem worldwide including cancer patients. Objectives. To know and to compare the prevalence of the metabolic syndrome in children with different neoplasms over chemotherapy treatment. Methods. Through prospective, longitudinal, comparative and analytical study, anthropometric, clinical and blood measurements were carried out in a group of pediatrics patients with cancer. Results. Fifty-eight patients participated. The global prevalence of the syndrome was 32.75 at the beginning, and 79.31% at the end. The 3 measurements were different for syndrome indicators as well as the number of positive patients (P <0.05). Blood pressure, height and weight were moderately associated with waist and hip perimeters. Conclusions. The metabolic syndrome prevalence in pediatric cancer patients is very high, with no difference due to cancer type.

Keywords : Metabolic syndrome; cancer; prevalence; chemotherapy.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License